Recent Developments in Adrenergic Receptor Polymorphisms in Essential Hypertension

Year 2025, Volume: 15 Issue: 1, 232 - 239, 28.03.2025

Burçin Erdat , İrem Atlıhan , Oya Orun

https://doi.org/10.33808/clinexphealthsci.1614451

Abstract

Objective: This review's goal is to provide an overview of the most recent data about the genetic foundations of adrenergic receptor polymorphisms in connection with essential hypertension (EH). Since EH is idiopathic, research is centered on its genetic underpinnings and significant interindividual differences in response to various therapies. Polymorphisms as an important element affecting individual disease susceptibility processes, are therefore, area of research interest for especially for genes that modulate variety of metabolic processes
Methods: A comprehensive, systematic literature search was conducted using a number of databases, including PubMed, Google Scholar, and Web of Science (WOS). Recent research in the field that looked into the connections between blood pressure, heart disease, hypertension, and vascular problems was taken into account. Only studies with common polymorphisms, uniform criteria and statistics were included in order to assess consistent information and provide a broad perspective.
Results: There are a limited number of studies in the literature after 2010 related to the adrenergic system polymorphisms, blood pressure, and/or essential hypertension. Genome-wide studies and meta-analyses reveal that there are several variants whose roles were supported by independent studies. ADRA1 Arg347Cys (rs1048101), ADRA2 C-1291G variant (rs1800544), ADRB1 Arg38Gly, ADRB2 Arg46Gly and ADRB3 Trp64ARg (rs4994) can be counted as major polymorphisms with their role verified by multiple researches.
Conclusion: Despite being supported by numerous research, the association between adrenergic system polymorphisms and essential hypertension cannot be conclusively established due to the unpredictability of study patient numbers, side effects, and inconsistent findings. Larger and more controlled population-based studies are required to provide a clear picture of the disease's variability and treatment responses.

Keywords

Adrenergic receptors, blood pressure, essential hypertension

Ethical Statement

An ethics committee approval was not required for the study.

References

• Krushkal J, Xiong M, Ferrell R, Sing CF, Turner ST, Boerwinkle E. Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Hum Mol Genet. 1998;7(9):1379-1383. DOI: 10.1093/hmg/7.9.1379
• Morris BJ, Benjafield AV, Lin RC. Essential hypertension: genes and dreams. Clin Chem Lab Med. 2003;41(7):834-844. https://doi.org/10.1515/CCLM.2003.127
• Geevarghese M, 3rd, Patel K, Gulati A, Ranjan AK. Role of adrenergic receptors in shock. Front Physiol. 2023;14:1094591. https://doi.org/10.3389/fphys.2023.1094591
• Raymond JR, Hnatowich M, Lefkowitz RJ, Caron MG. Adrenergic receptors. Models for regulation of signal transduction processes. Hypertension 1990;15(2):119-131. https://doi.org/10.1161/01.hyp.15.2.119
• Wu Y, Zeng L, Zhao S. Ligands of adrenergic receptors: A structural point of view. Biomolecules 2021;11(7): 936. https://doi.org/10.3390/biom11070936
• Badino P, Odore R, Re G. Are so many adrenergic receptor subtypes really present in domestic animal tissues? A pharmacological perspective. Vet J. 2005;170(2):163-174. https://doi.org/10.1016/j.tvjl.2004.05.015
• Orun O, Nacar C, Cabadak H, Tiber PM, Dogan Y, Guneysel O, Fak AS, Kan B. Investigation of the association between dopamine D1 receptor gene polymorphisms and essential hypertension in a group of Turkish subjects. Clin Exp Hypertens. 2011;33(6):418-421. https://doi.org/10.3109/10641963.2011.561898
• Reder NP, Tayo BO, Salako B, Ogunniyi A, Adeyemo A, Rotimi C, Cooper RS. Adrenergic alpha-1 pathway is associated with hypertension among Nigerians in a pathway-focused analysis. PLoS One 2012;7(5):e37145. https://doi.org/10.1371/journal.pone.0037145
• Nunes RA, Barroso LP, Pereira Ada C, Krieger JE, Mansur AJ. Gender-related associations of genetic polymorphisms of alpha-adrenergic receptors, endothelial nitric oxide synthase and bradykinin B2 receptor with treadmill exercise test responses. Open Heart. 2014;1(1):e000132. https://doi.org/10.1136/openhrt-2014-000132
• Adefurin A, Ghimire LV, Kohli U, Muszkat M, Sofowora GG, Li C, Levinson RT, Paranjape SY, Stein CM, Kurnik D. Genetic variation in the alpha(1B)-adrenergic receptor and vascular response. Pharmacogenomics J. 2017;17(4):366-371. https://doi.org/10.1038/tpj.2016.29
• Berends AMA, Bolhuis MS, Nolte IM, Buitenwerf E, Links TP, Timmers H, Feelders RA, Eekhoff EMW, Corssmit EPM, Bisschop PH, Haak HR, van Schaik RHN, El Bouazzaoui S, Wilffert B, Kerstens MN. Influence of receptor polymorphisms on the response to alpha-adrenergic receptor blockers in pheochromocytoma patients. Biomedicines 2022;10(4):896. https://doi.org/10.3390/biomedicines10040896
• Sõber S, Org E, Kepp K, Juhanson P, Eyheramendy S, Gieger C, Lichtner P, Klopp N, Veldre G, Viigimaa M, Döring A, Putku M, Kelgo P, Shaw-Hawkins S, Howard P, Onipinla A, Dobson RJ, Newhouse SJ, Brown M, Dominiczak A, Connell J, Samani N, Farrall M, Caulfield MJ, Munroe PB, Illig T, Wichmann HE, Meitinger T, Laan M. Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array. PLoS One 2009;4(6):e6034. https://doi.org/10.1371/journal.pone.0006034
• Li JL, Canham RM, Vongpatanasin W, Leonard D, Auchus RJ, Victor RG. Do allelic variants in alpha2A and alpha2C adrenergic receptors predispose to hypertension in blacks? Hypertension 2006;47(6):1140-6. https://doi.org/10.1161/01.HYP.0000217972.80731.ef
• Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, Najjar SS, Zhao JH, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet. 2009;41(6):666-676. https://doi.org/10.1038/ng.361
• Kurnik D, Muszkat M, Li C, Sofowora GG, Friedman EA, Scheinin M, Wood AJ, Stein CM. Genetic variations in the alpha(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine. Circ Cardiovasc Genet. 2011;4(2):179-187. https://doi.org/10.1161/CIRCGENETICS.110.957662
• Yagar S, Yavas S, Karahalil B. The role of the ADRA2A C1291G genetic polymorphism in response to dexmedetomidine on patients undergoing coronary artery surgery. Mol Biol Rep. 2011;38(5):3383-3389. https://doi.org/10.1007/s11033-010-0446-y
• Kelsey RM, Alpert BS, Dahmer MK, Krushkal J, Quasney MW. Alpha-adrenergic receptor gene polymorphisms and cardiovascular reactivity to stress in Black adolescents and young adults. Psychophysiology 2012;49(3):401-412. https://doi.org/10.1111/j.1469-8986.2011.01319.x
• Eldeeb HM, Elgharabawy RM, Abd Elmoniem AE, Ahmed AA. Alpha-2 beta-adrenergic receptor (301-303 I/D) gene polymorphism in hypertension and type 2 diabetes mellitus diseases among Saudi cases in the Qassim region. Sci Prog. 2021;104(2):368504211012162. https://doi.org/10.1177/00368504211012162
• Bristow MR, Anderson FL, Port JD, Skerl L, Hershberger RE, Larrabee P, O'Connell JB, Renlund DG, Volkman K, Murray J. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation 1991;84(3):1024-1039. https://doi.org/10.1161/01.cir.84.3.1024
• Bristow MR, Hershberger RE, Port JD, Gilbert EM, Sandoval A, Rasmussen R, Cates AE, Feldman AM. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation. 1990;82(2 Suppl):I12–I25.
• Zhu H, Poole J, Lu Y, Harshfield GA, Treiber FA, Snieder H, Dong Y. Sympathetic nervous system, genes and human essential hypertension. Curr Neurovasc Res. 2005;2(4):303-317. https://doi.org/10.2174/156720205774322575
• Taylor MR, Bristow MR. The emerging pharmacogenomics of the beta-adrenergic receptors. Congest Heart Fail. 2004;10(6):281-288. https://doi.org/10.1111/j.1527-5299.2004.02019.x
• Mason DA, Moore JD, Green SA, Liggett SB. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem. 1999;274(18):12670-12674. https://doi.org/10.1074/jbc.274.18.12670
• Maqbool A, Hall AS, Ball SG, Balmforth AJ. Common polymorphisms of beta1-adrenoceptor: Identification and rapid screening assay. Lancet 1999;353(9156):897. https://doi.org/10.1016/s0140-6736(99)00549-8
• Wu D, Li G, Deng M, Song W, Huang X, Guo X, Wu Z, Wu S, Xu J. Associations between ADRB1 and CYP2D6 gene polymorphisms and the response to beta-blocker therapy in hypertension. J Int Med Res. 2015;43(3):424-34. https://doi.org/10.1177/0300060514563151
• Chen L, Xiao T, Chen L, Xie S, Deng M, Wu D. The association of ADRB1 and CYP2D6 polymorphisms with antihypertensive effects and analysis of their contribution to hypertension risk. Am J Med Sci. 2018;355(3):235-239. https://doi.org/10.1016/j.amjms.2017.11.002
• Wang H, Liu J, Liu K, Liu Y, Wang Z, Lou Y, Niu Q, Gu W, Wang L, Li M, Zhu X, Wen S. beta1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: A meta-analysis. Mol Biol Rep. 2013;40(6):4055-4063. https://doi.org/10.1007/s11033-012-2483-1
• Johnson AD, Newton-Cheh C, Chasman DI, Ehret GB, Johnson T, Rose L, Rice K, Verwoert GC, Launer LJ, Gudnason V, Larson MG, Chakravarti A, Psaty BM, Caulfield M, van Duijn CM, Ridker PM, Munroe PB, Levy D; Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium; Global BPgen Consortium;, Women's Genome Health Study. Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals. Hypertension 2011;57(5):903-910. https://doi.org/10.1161/HYPERTENSIONAHA.110.158667
• Ma ST, Zhao W, Liu B, Jia RY, Zhao CJ, Cui LQ. Association between beta1 adrenergic receptor gene Arg389Gly polymorphism and risk of heart failure: A meta-analysis. Genet Mol Res. 2015;14(2):5922-5929. https://doi.org/10.4238/2015.June.1.9
• Varakantham V, Kurakula Sailoo AK, Nagalla B, Bharatraj DK. mRNA expression profile in peripheral blood mononuclear cells based on ADRB1 Ser49Gly and Arg389Gly polymorphisms in essential hypertension - A case-control pilot investigation in South Indian population. Clin Chem Lab Med. 2018;56(8):1230-1237. https://doi.org/10.1515/cclm-2017-0882
• Raimoglou D, Izgi C, Enar R, Karpuz MH, Karadag B, Iktimur B, Raimoglu U, Soysal AU, Kargin OA, Guven M, Malikova N, Citak E, Yurtseven E, Durmaz E. Structural and functional impact of adrenoceptor beta-1 gene polymorphism in patients with hypertrophic cardiomyopathy and response to beta-blocker therapy. Anatol J Cardiol. 2024;28(3):150-157. https://doi.org/10.14744/AnatolJCardiol.2023.3898
• Liggett SB. Molecular and genetic basis of beta2-adrenergic receptor function. J Allergy Clin Immunol. 1999;104(2 Pt 2):S42-46. https://doi.org/10.1016/s0091-6749(99)70272-1
• Timmermann B, Mo R, Luft FC, Gerdts E, Busjahn A, Omvik P, Li GH, Schuster H, Wienker TF, Hoehe MR, Lund-Johansen P. Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. Kidney Int. 1998;53(6):1455-1460. https://doi.org/10.1046/j.1523-1755.1998.00926.x
• Lou Y, Liu J, Li Y, Liu Y, Wang Z, Liu K, Wu H, Niu Q, Gu W, Guo Y, Li Z, Wen S. Association study of the beta2-adrenergic receptor gene polymorphisms and hypertension in the Northern Han Chinese. PLoS One 2011;6(4):e18590. https://doi.org/10.1371/journal.pone.0018590
• Cai W, Yin L, Cheng J, Wang S, Wei Y, Cao W, Cheng J. Relationship between the single nucleotide polymorphisms of β₂-adrenergic receptor 5'-regulatory region and essential hypertension in Chinese Kazakh ethnic minority group. International Journal of Clinical and Experimental Pathology.2015;8(7):8358-8366. ISSN:1936-2625/IJCEP0003427
• Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry1994;33(32):9414-9419. https://doi.org/10.1021/bi00198a006
• Yan L, Wang H, Liu P, Wang M, Chen J, Zhao X. Association between the A46G polymorphism (rs1042713) in the beta2-adrenergic receptor gene and essential hypertension susceptibility in the Chinese population: A PRISMA-compliant meta-analysis. Medicine (Baltimore). 2020;99(46):e23164. https://doi.org/10.1097/MD.0000000000023164
• Pojoga L, Kolatkar NS, Williams JS, Perlstein TS, Jeunemaitre X, Brown NJ, Hopkins PN, Raby BA, Williams GH. Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension. Hypertension 2006;48(5):892-900. https://doi.org/10.1161/01.HYP.0000244688.45472.95
• Maamor NH, Ismail J, Malek KA, Yusoff K, Boon-Peng H. AGT, CYP11B2 & ADRB2 gene polymorphism & essential hypertension (HT): A meta-analysis. Indian J Med Res. 2024;159(6):619-626. https://doi.org/10.25259/ijmr_520_23
• Li YY, Lu XZ, Wang H, Zhou YH, Yang XX, Geng HY, Gong G, Kim HJ. ADRB3 Gene Trp64Arg polymorphism and essential hypertension: A meta-analysis including 9,555 subjects. Front Genet. 2018;9:106. https://doi.org/10.3389/fgene.2018.00106